Key facts
- It has raised $11.0M; the latest was Later Stage VC ($2.4M) in Apr 2025.
- Notable investors include Blue Partners Asset Management, PIUM Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for V&Co.
- ·The full record, as it builds
Funding rounds
No funding rounds for V&Co. are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About V&Co.
Operator of a medical specialist company intended to advance dermatology and plastic surgery in Korea. The company's platform integrates skin microbiome research data and offers a range of services, including medical supplies, health supplements, and precision devices, enabling healthcare providers and beauty professionals to deliver innovative treatments and enhance overall client satisfaction through scientifically backed methodologies.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2015
- Employees
- 44
- Website
- vnco.co.kr/
- Ownership
- Privately Held (backing)
V&Co. doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in V&Co. shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on V&Co. in its N-PORT filings yet. We sweep new filings monthly.